Paraneoplastic anti-SRP antibody positive immune-mediated necrotizing myopathy in a young female associated with lymphoma. [PDF]
Heugenhauser J +7 more
europepmc +1 more source
Outcome predictors of immune-mediated necrotizing myopathy—a retrospective, multicentre study
Objectives: Evidence-based treatment protocols are currently lacking for immune-mediated necrotizing myopathy (IMNM). In this multicentre retrospective study, we examined baseline clinical characteristics and treatment variables that may predict short ...
Christopher Oldmeadow (21131288) +4 more
core
Rituximab in the treatment of anti-HMGCR immune-mediated necrotizing myopathy: Two cases successfully treated. [PDF]
Micheli G +10 more
europepmc +1 more source
Clinical Characteristics and Management of Statin-Associated Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Immune-Mediated Necrotizing Myopathy. [PDF]
Yoon J +8 more
europepmc +1 more source
Efgartigimod combined with steroids as a fast-acting therapy for anti-SRP immune-mediated necrotizing myopathy. [PDF]
Peng Q +5 more
europepmc +1 more source
Dysphagia During Pharyngeal and Esophageal Phase of Seronegative Immune-Mediated Necrotizing Myopathy: A Case Report. [PDF]
Takaku N +7 more
europepmc +1 more source
The clinical value of lymphocyte percentages and the monocyte-to-lymphocyte ratio in differentiating immune-mediated necrotizing myopathy from dermatomyositis. [PDF]
Ma X, Huo K, Gao H, Ge H.
europepmc +1 more source
Anti-3-hydroxy-3-methylglutaryl coenzyme A reductase immune-mediated necrotizing myopathy with a CD68+ lymphohistiocytic cutaneous eruption. [PDF]
Park Y +3 more
europepmc +1 more source
Statin-Associated Immune-Mediated Necrotizing Myopathy With Dual Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase (Anti-HMGCR) and Anti-OJ Positivity: A Case Report of Fulminant Weakness and Respiratory Failure. [PDF]
Rahman MA +4 more
europepmc +1 more source

